ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+15.58%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$86.2M
AUM Growth
+$86.2M
(+2.3%)
Cap. Flow
-$3.59M
Cap. Flow
% of AUM
-4.16%
Top 10 Holdings %
Top 10 Hldgs %
59.3%
Holding
39
New
11
Increased
6
Reduced
15
Closed
7
Top Buys
| 1 |
Insmed
INSM
|
$6.66M |
| 2 |
Ionis Pharmaceuticals
IONS
|
$2.84M |
| 3 |
HMSY
HMS Holdings Corp.
HMSY
|
$2.82M |
| 4 |
NVTA
Invitae Corporation
NVTA
|
$2.75M |
| 5 |
NITE
Nightstar Therapeutics plc American Depositary Shares
NITE
|
$2.5M |
Top Sells
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$4.46M |
| 2 |
Gilead Sciences
GILD
|
$4.05M |
| 3 |
Medtronic
MDT
|
$3.79M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$3.58M |
| 5 |
PTC Therapeutics
PTCT
|
$3.46M |
Sector Composition
| 1 | Healthcare | 90.93% |
| 2 | Industrials | 3.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PTC Therapeutics
PTCT
$3.92B
| $7.11M | 8.25% | 355,456 -172,659 | -33% | -$3.46M |
|
2
Centene
CNC
$14.3B
| $6.76M | 7.84% | 69,834 +13,982 | +25% | +$1.35M |
|
|
3
Insmed
INSM
$28.8B
| $6.66M | 7.72% | +213,376 | New | +$6.66M |
|
4
Jazz Pharmaceuticals
JAZZ
$7.75B
| $6.16M | 7.14% | 42,092 +10,753 | +34% | +$1.57M |
|
5
UnitedHealth
UNH
$281B
| $4.91M | 5.69% | 25,062 -856 | -3% | -$168K |
|
6
Sarepta Therapeutics
SRPT
$1.78B
| $4.77M | 5.53% | 105,066 -53,744 | -34% | -$2.44M |
|
7
Bio-Rad Laboratories Class A
BIO
$8.06B
| $4.5M | 5.22% | 20,242 -127 | -0.6% | -$28.2K |
|
8
Quest Diagnostics
DGX
$20.3B
| $3.58M | 4.15% | 38,220 +7,466 | +24% | +$699K |
|
9
Acadia Healthcare
ACHC
$2.12B
| $3.48M | 4.04% | 72,889 -9,805 | -12% | -$468K |
|
10
Amicus Therapeutics
FOLD
$2.34B
| $3.21M | 3.73% | 213,059 -188,850 | -47% | -$2.85M |
|
11
Neurocrine Biosciences
NBIX
$13.8B
| $3.16M | 3.66% | 51,497 +17,467 | +51% | +$1.07M |
|
12
Natera
NTRA
$23.1B
| $3.06M | 3.54% | 237,118 +173,307 | +272% | +$2.23M |
|
|
13
Ionis Pharmaceuticals
IONS
$6.79B
| $2.84M | 3.29% | +55,965 | New | +$2.84M |
|
|
HMSY
14
DELISTED
HMS Holdings Corp.
HMSY
| $2.82M | 3.27% | +141,906 | New | +$2.82M |
|
|
NVTA
15
DELISTED
Invitae Corporation
NVTA
| $2.75M | 3.19% | +293,819 | New | +$2.75M |
|
16
Tactile Systems Technology
TCMD
$297M
| $2.57M | 2.98% | 82,976 +22,056 | +36% | +$683K |
|
|
NITE
17
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $2.5M | 2.89% | +130,007 | New | +$2.5M |
|
18
DURECT Corp
DRRX
$59.6M
| $1.57M | 1.82% | 888,197 -160,276 | -15% | -$284K |
|
|
JUNO
19
DELISTED
Juno Therapeutics, Inc.
JUNO
| $1.38M | 1.6% | +30,760 | New | +$1.38M |
|
20
Inogen
INGN
$216M
| $1.34M | 1.56% | 14,113 -6,629 | -32% | -$630K |
|
|
ALDR
21
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $1.29M | 1.49% | 105,228 -61,524 | -37% | -$754K |
|
|
22
Medtronic
MDT
$119B
| $1.27M | 1.47% | 16,295 -48,741 | -75% | -$3.79M |
|
|
CLVS
23
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.15M | 1.34% | 14,008 -18,377 | -57% | -$1.51M |
|
|
NVRO
24
DELISTED
NEVRO CORP.
NVRO
| $1.07M | 1.24% | 11,804 -49,089 | -81% | -$4.46M |
|
|
TVTY
25
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $1.05M | 1.21% | +25,654 | New | +$1.05M |
|